Caplight Directory>Companies>Exonate-preview>Exonate


Exonate

Exonate

Private
CambridgeHealthcare & Life Scienceshttps://www.exonate.com

Last Round

VC Round

Jan 3, 2019

Total Funding Raised

$8.61M

Company Overview

Exonate is a biopharmaceutical company developing novel, non-invasive, small-molecule therapeutics for patients with retinal vascular diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Revenue Share, Government Contracts

AI Layer

Non-AI

Keywords

topical eye dropsSRPK1 inhibitorwet AMDdiabetic macular oedemaDMEsmall-molecule drugsmRNA splicing modulationVEGF modulationretinal disease therapynon-invasive treatmenteye injections alternativeclinical-stage biotechdiabetic retinopathypharma partnershipsdrug licensingwet age-related macular degenerationNPDREXN407

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Exonate Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Exonate Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
VC RoundJan 3, 2019
GrantFeb 6, 2017
AngelNov 30, 2016
SeedOct 5, 2015
View all Funding Rounds

Key People

Founding team and executive leadership

Loïc Lhuillier

Chief Operating Officer

Executive Team

Exonate Investors

Notable investors and investment history

InvestorRounds
Angel CoFundSeed, Angel, VC Round
o2h venturesAngel, VC Round
University of Bristol Enterprise FundAngel, VC Round
UniseedAngel, VC Round
Parkwalk AdvisorsAngel, VC Round
Wren CapitalAngel, VC Round
Martlet CapitalAngel, VC Round
View all Investors

Exonate Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Exonate Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Exonate's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge
Employee Range15
Year Founded2013
Last FundingJan 3, 2019

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.